{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:08:24Z","timestamp":1791432504215,"version":"4.3.3"},"reference-count":42,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["DA053083"],"award-info":[{"award-number":["DA053083"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["DA060644"],"award-info":[{"award-number":["DA060644"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["AA030577"],"award-info":[{"award-number":["AA030577"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ajpath.2026.01.003","type":"journal-article","created":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T06:26:35Z","timestamp":1769927195000},"page":"1188-1204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Leukocytic Dopamine D2 Receptors as Biomarkers for Brain Dopamine Levels in Parkinson Disease"],"prefix":"10.1016","volume":"196","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5258-9126","authenticated-orcid":false,"given":"Christina A.","family":"Nelson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7526-4869","authenticated-orcid":false,"given":"J. Daniel","family":"Obray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles R.","family":"Roll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pacen E.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William T.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5180-537X","authenticated-orcid":false,"given":"Caylor W.","family":"Hafen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4212-8995","authenticated-orcid":false,"given":"Matthew D.","family":"Burris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim H.","family":"Manwaring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel N.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3688-2191","authenticated-orcid":false,"given":"K. Scott","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9060-0485","authenticated-orcid":false,"given":"Sandra","family":"Hope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike H.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan T.","family":"Yorgason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott C.","family":"Steffensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2026.01.003_bib1","first-page":"1","article-title":"The role of dopamine and its dysfunction as a consequence of oxidative stress","volume":"2016","author":"Ju\u00e1rez Olgu\u00edn","year":"2016","journal-title":"Oxid Med Cell Long"},{"key":"10.1016\/j.ajpath.2026.01.003_bib2","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.ajpath.2015.09.023","article-title":"Dopaminergic neurons and brain reward pathways","volume":"186","author":"Luo","year":"2016","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2026.01.003_bib3","article-title":"Neurobiology of schizophrenia: a comprehensive review","volume":"14","author":"Luvsannyam","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.ajpath.2026.01.003_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0306-4530(81)90044-5","article-title":"Tuberoinfundibular dopamine neurons and the regulation of prolactin secretion","volume":"6","author":"Gudelsky","year":"1981","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.ajpath.2026.01.003_bib5","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/brain\/122.8.1437","article-title":"The substantia nigra of the human brain, II: patterns of loss of dopamine-containing neurons in Parkinson's disease","volume":"122","author":"Damier","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.ajpath.2026.01.003_bib6","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.neubiorev.2004.05.001","article-title":"The somatodendritic release of dopamine in the ventral tegmental area and its regulation by afferent transmitter systems","volume":"28","author":"Adell","year":"2004","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.ajpath.2026.01.003_bib7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuroscience.2014.01.025","article-title":"Ford CP: The role of D2-autoreceptors in regulating dopamine neuron activity and transmission","volume":"282","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.ajpath.2026.01.003_bib8","doi-asserted-by":"crossref","first-page":"12700","DOI":"10.1523\/JNEUROSCI.3371-07.2007","article-title":"Profound decreases in dopamine release in striatum in detoxified alcoholics: possible orbitofrontal involvement","volume":"27","author":"Volkow","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.ajpath.2026.01.003_bib9","doi-asserted-by":"crossref","first-page":"E1498","DOI":"10.1073\/pnas.1500450112","article-title":"Increased dopamine D2 receptor activity in the striatum alters the firing pattern of dopamine neurons in the ventral tegmental area","volume":"112","author":"Krabbe","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2026.01.003_bib10","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1126\/science.3854","article-title":"Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs","volume":"192","author":"Creese","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2026.01.003_bib11","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.neuropharm.2013.06.031","article-title":"Imaging addiction: D2 receptors and dopamine signaling in the striatum as biomarkers for impulsivity","volume":"76","author":"Trifilieff","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ajpath.2026.01.003_bib12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neuint.2019.01.022","article-title":"Disentangling the diverse roles of dopamine D2 receptors in striatal function and behavior","volume":"125","author":"Gallo","year":"2019","journal-title":"Neurochem Int"},{"key":"10.1016\/j.ajpath.2026.01.003_bib13","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.pharmthera.2005.12.001","article-title":"What has been learnt from study of dopamine receptors in Parkinson's disease?","volume":"111","author":"Hurley","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.ajpath.2026.01.003_bib14","doi-asserted-by":"crossref","first-page":"5570","DOI":"10.1210\/en.2010-0745","article-title":"Minireview: new roles for peripheral dopamine on metabolic control and tumor growth: let's seek the balance","volume":"151","author":"Rub\u00ed","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.ajpath.2026.01.003_bib15","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1385\/ENDO:12:3:237","article-title":"Role of dopamine in malignant tumor growth","volume":"12","author":"Basu","year":"2000","journal-title":"Endocrine"},{"key":"10.1016\/j.ajpath.2026.01.003_bib16","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0165-5728(02)00280-1","article-title":"Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study","volume":"132","author":"McKenna","year":"2002","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.ajpath.2026.01.003_bib17","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00213-010-2087-1","article-title":"Peripheral biomarkers of cognitive response to dopamine receptor agonist treatment","volume":"214","author":"Ersche","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ajpath.2026.01.003_bib18","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1073\/pnas.98.2.625","article-title":"A peripheral marker for schizophrenia: increased levels of D3 dopamine receptor mRNA in blood lymphocytes","volume":"98","author":"Ilani","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2026.01.003_bib19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0047-6374(00)00183-4","article-title":"Reduced density of dopamine D2-like receptors on peripheral blood lymphocytes in Alzheimer's disease","volume":"120","author":"Barbanti","year":"2000","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.ajpath.2026.01.003_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1468-2982.2000.00001.x","article-title":"Migraine patients show an increased density of dopamine D3 and D4 receptors on lymphocytes","volume":"20","author":"Barbanti","year":"2000","journal-title":"Cephalalgia"},{"key":"10.1016\/j.ajpath.2026.01.003_bib21","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1212\/WNL.46.3.791","article-title":"Decrease of the D3 dopamine receptor mRNA expression in lymphocytes from patients with Parkinson's disease","volume":"46","author":"Nagai","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.ajpath.2026.01.003_bib22","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/1531-8257(199909)14:5<764::AID-MDS1008>3.0.CO;2-W","article-title":"Increased expression of dopamine receptors on lymphocytes in Parkinson's disease","volume":"14","author":"Barbanti","year":"1999","journal-title":"Mov Disord"},{"key":"10.1016\/j.ajpath.2026.01.003_bib23","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.pnpbp.2004.01.009","article-title":"Lymphocytes as a neural probe: potential for studying psychiatric disorders","volume":"28","author":"Gladkevich","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.ajpath.2026.01.003_bib24","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3389\/fneur.2018.00155","article-title":"Peripheral dopamine in restless legs syndrome","volume":"9","author":"Mitchell","year":"2018","journal-title":"Front Neurol"},{"key":"10.1016\/j.ajpath.2026.01.003_bib25","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/mp.2017.107","article-title":"PET imaging of dopamine-D2 receptor internalization in schizophrenia","volume":"23","author":"Weinstein","year":"2018","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.ajpath.2026.01.003_bib42","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3233\/JPD-2011-11023","article-title":"MPTP mouse models of Parkinson\u2019s disease: an update","volume":"1","author":"Meredith","year":"2011","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.ajpath.2026.01.003_bib26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nprot.2006.342","article-title":"Protocol for the MPTP mouse model of Parkinson's disease","volume":"2","author":"Jackson-Lewis","year":"2007","journal-title":"Nat Protoc"},{"key":"10.1016\/j.ajpath.2026.01.003_bib27","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0306-4522(96)00545-3","article-title":"In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining","volume":"77","author":"Tatton","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.ajpath.2026.01.003_bib28","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/(SICI)1099-0801(199601)10:1<40::AID-BMC548>3.0.CO;2-5","article-title":"Plasma catecholamine assays: calibration with spiked plasma versus aqueous solutions","volume":"10","author":"Candito","year":"1996","journal-title":"Biomed Chromatogr"},{"key":"10.1016\/j.ajpath.2026.01.003_bib29","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1093\/clinchem\/33.12.2209","article-title":"Liquid-chromatographic measurement of catecholamines and metabolites in plasma and urine","volume":"33","author":"Foti","year":"1987","journal-title":"Clin Chem"},{"key":"10.1016\/j.ajpath.2026.01.003_bib30","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.3988","article-title":"Transcardiac perfusion of the mouse for brain tissue dissection and fixation","volume":"11","author":"Wu","year":"2021","journal-title":"Bio Protoc"},{"key":"10.1016\/j.ajpath.2026.01.003_bib31","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41531-022-00333-8","article-title":"DAT and TH expression marks human Parkinson's disease in peripheral immune cells","volume":"8","author":"Gopinath","year":"2022","journal-title":"NPJ Parkinsons Dis"},{"key":"10.1016\/j.ajpath.2026.01.003_bib32","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3233\/JPD-240030","article-title":"Immunophenotyping tracks motor progression in Parkinson's disease associated with a TH mutation","volume":"14","author":"Gopinath","year":"2024","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.ajpath.2026.01.003_bib33","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.phrs.2015.12.029","article-title":"Dopaminergic drugs in type 2 diabetes and glucose homeostasis","volume":"109","author":"Lopez Vicchi","year":"2016","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.ajpath.2026.01.003_bib34","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s12264-022-00848-3","article-title":"Intestinal dopamine receptor D2 is required for neuroprotection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration","volume":"38","author":"Peng","year":"2022","journal-title":"Neurosci Bull"},{"key":"10.1016\/j.ajpath.2026.01.003_bib35","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1530-0277.2009.00899.x","article-title":"Acute and chronic ethanol modulate dopamine D2-subtype receptor responses in ventral tegmental area GABA neurons","volume":"33","author":"Ludlow","year":"2009","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.ajpath.2026.01.003_bib36","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/acer.14775","article-title":"The peripheral dopamine 2 receptor antagonist domperidone attenuates ethanol enhancement of dopamine levels in the nucleus accumbens","volume":"46","author":"Obray","year":"2022","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.ajpath.2026.01.003_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.944243","article-title":"Dopamine D2-subtype receptors outside the blood-brain barrier mediate enhancement of mesolimbic dopamine release and conditioned place preference by intravenous dopamine","volume":"16","author":"Obray","year":"2022","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.ajpath.2026.01.003_bib38","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","article-title":"Epidemiology of Parkinson's disease","volume":"124","author":"Tysnes","year":"2017","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/j.ajpath.2026.01.003_bib39","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.smrv.2011.05.002","article-title":"Epidemiology of restless legs syndrome: a synthesis of the literature","volume":"16","author":"Ohayon","year":"2012","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.ajpath.2026.01.003_bib40","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/schbul\/sby058","article-title":"Global epidemiology and burden of schizophrenia: findings from the global burden of disease study 2016","volume":"44","author":"Charlson","year":"2018","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.ajpath.2026.01.003_bib41","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00439-012-1168-0","article-title":"Epidemiology of substance use disorders","volume":"131","author":"Merikangas","year":"2012","journal-title":"Hum Genet"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944026000283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944026000283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T10:36:38Z","timestamp":1776767798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944026000283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0002944026000283"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2026.01.003","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Leukocytic Dopamine D2 Receptors as Biomarkers for Brain Dopamine Levels in Parkinson Disease","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2026.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Investigative Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}